MAUSCHITZ, Matthias M.; VERZIJDEN, Timo; SCHUSTER, Alexander K.; ELBAZ, Hisham; PFEIFFER, Norbert; KHAWAJA, Anthony; LUBEN, Robert N.; FOSTER, Paul J.; RAUSCHER, Franziska G.; WIRKNER, Kerstin; KIRSTEN, Toralf; JONAS, Jost B.; BIKBOV, Mukharram M.; HOGG, Ruth; PETO, Tunde; COUGNARD-GREGOIRE, Audrey; BERTELSEN, Geir; ERKE, Maja Gran; TOPOUZIS, Fotis; GIANNOULIS, Dimitrios A.; BRANDL, Caroline; HEID, Iris M.; CREUZOT-GARCHER, Catherine P.; GABRIELLE, Pierre-Henry; HENSE, Hans-Werner; PAULEIKHOFF, Daniel; BARRETO, Patricia; COIMBRA, Rita; PIERMAROCCHI, Stefano; DAIEN, Vincent; HOLZ, Frank G.; DELCOURT, Cecile; FINGER, Robert P.

doi:10.1136/bjo-2022-321985

Langue

Article de revue

Ce document a été publié dans

British Journal of Ophthalmology. 2022-11-07

Résumé en anglais

BACKGROUND/AIMS: To investigate the association of commonly used systemic medications with prevalent age-related macular degeneration (AMD) in the general population. METHODS: We included 38 694 adults from 14 population-based and hospital-based studies from the European Eye Epidemiology consortium. We examined associations between the use of systemic medications and any prevalent AMD as well as any late AMD using multivariable logistic regression modelling per study and pooled results using random effects meta-analysis. RESULTS: Between studies, mean age ranged from 61.5±7.1 to 82.6±3.8 years and prevalence ranged from 12.1% to 64.5% and from 0.5% to 35.5% for any and late AMD, respectively. In the meta-analysis of fully adjusted multivariable models, lipid-lowering drugs (LLD) and antidiabetic drugs were associated with lower prevalent any AMD (OR 0.85, 95% CI=0.79 to 0.91 and OR 0.78, 95% CI=0.66 to 0.91). We found no association with late AMD or with any other medication. CONCLUSION: Our study indicates a potential beneficial effect of LLD and antidiabetic drug use on prevalence of AMD across multiple European cohorts. Our findings support the importance of metabolic processes in the multifactorial aetiology of AMD.< Réduire

URI

https://oskar-bordeaux.fr/handle/20.500.12278/171550

DOI

http://dx.doi.org/10.1136/bjo-2022-321985

Unités de recherche

Bordeaux Population Health Research Center (BPH) - UMR 1219

Voir/Ouvrir

Métadonnées

Partager cette publication !

Licence d’utilisation du document

Association of lipid-lowering drugs and antidiabetic drugs with age-related macular degeneration: a meta-analysis in Europeans

Langue

Ce document a été publié dans

Résumé en anglais

URI

DOI

Unités de recherche